The tubulysin analogue KEMTUB10 induces apoptosis in breast cancer cells via p53, Bim and Bcl-2.
about
Antimitotic drugs in the treatment of cancerKEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation.Synthesis and Superpotent Anticancer Activity of Tubulysins Carrying Non-hydrolysable N-Substituents on Tubuvaline.
P2860
The tubulysin analogue KEMTUB10 induces apoptosis in breast cancer cells via p53, Bim and Bcl-2.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
The tubulysin analogue KEMTUB1 ...... cells via p53, Bim and Bcl-2.
@en
type
label
The tubulysin analogue KEMTUB1 ...... cells via p53, Bim and Bcl-2.
@en
prefLabel
The tubulysin analogue KEMTUB1 ...... cells via p53, Bim and Bcl-2.
@en
P2093
P2860
P1476
The tubulysin analogue KEMTUB1 ...... cells via p53, Bim and Bcl-2.
@en
P2093
Ian N Fleming
Matteo Zanda
Monica Sani
Oluwafunmilayo F Lamidi
Paolo Lazzari
P2860
P2888
P304
P356
10.1007/S00432-015-1921-6
P577
2015-01-30T00:00:00Z